Clinical trial
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With…
NCT00004005 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00004005 |
|---|---|
| Title | Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin |
| Official title | Irinotecan and 5-Fluorouracil/Leucovorin for Patients With Colorectal Carcinoma and Other Refractory Tumors |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma of Unknown Primary, Colorectal Cancer, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | fluorouracil, irinotecan hydrochloride, leucovorin calcium, conventional surgery, radiation therapy |
| Enrollment | 12 |
| Start date | Sep 1, 1998 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: